FDA released new guidance considerations for the design and conduct of externally controlled trials for Drug and Biological products. This industry guidance provides recommendations to sponsors and investigators considering the use of externally controlled clinical trials to provide evidence of the safety and effectiveness of a drug product. The guidance addresses considerations for the design and analysis of externally controlled trials to study the effectiveness and safety of drugs.

Download draft guidance here.